课题基金 / 基金详情

Basic and clinical studies on the role of inflammatory mechanisms in the pathogenesis ischemic heart disease

Basic and clinical studies on the role of inflammatory mechanisms in the pathogenesis ischemic heart disease
炎症机制在缺血性心脏病发病机制中的基础与临床研究
批准号:
12470158
负责人:
SHIMOKAWA Hiroaki
金额:
$8.77万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

SHIMOKAWA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) Rho-kinase is substantially involved in the inflammatory mechanisms of arteriosclerosis. The expression of Rho-kinase in vascular smooth muscle cells is upregulated by inflammatory stimuli, such as angiotensin II and IL-1β with an involvement of Nf-_KB.2) Rho-kinase mediates hypoxia-induced downregulation of endothelial NO synthase (eNOS) in cultured human endothelial cells. Hydroxyfasudil, a specific Rho-kinase inhibitor, prevents the hypoxia-induced downregufayion of eNOS.3) Long-term inhibition of Rho-kinase suppresses in-stent restenosis in porcine coronary arteries, in which multiple mechanisms are involved, including enhancement of VSMC apoptosis, suppression of MCP-1 expression and inflammatory cell recruitment, and suppression of collagen synthesis through TGF-bl inhibition.4) Long-term inhibition of Rho-kinase suppresses angiotensin Il-induced formation of cardiovascular lesions by multiple mechanisms, including suppressions of NAD(P)H and TGF-β1 expression and of superoxide production.5) Long-term inhibition of Rho-kinase suppresses cardiac allograft vasculopathy, in which inhibition of the expression of macrophage migration inhibitory factor (MIF) is involved.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
Masumoto A, Mohri M, Shimokawa H, et al.: "Suppression of coronary artery spasm by a Rho-kinase inhibitor in patients with vasospastic angina"Circulation. (in press). (2002)
Masumoto A、Mohri M、Shimokawa H 等人:“血管痉挛性心绞痛患者通过 Rho 激酶抑制剂抑制冠状动脉痉挛”循环。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimokawa H.: "Proceedings of the International Symposium of Coronary Artery Spasm.(Yasue H,ed.)"Axel Springer Japan Publishing Inc.. 91-95 (2000)
Shimokawa H.:“冠状动脉痉挛国际研讨会论文集。(Yasue H,ed.)”Axel Springer Japan Publishing Inc.. 91-95 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takemoto M, et al.: "Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase"Circulation. 106. 57-62 (2002)
Takemoto M 等人:“Rho 激酶介导缺氧诱导的内皮一氧化氮合酶下调”循环。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masumoto A, Mohri M, Shimokawa H, et al.: "Suppression of coronary artery spasm by a Rho-kinase inhibitor fasudil in patients with vasospastic angina"Circulation. 105. 1545-1547 (2002)
Masumoto A、Mohri M、Shimokawa H 等人:“Rho 激酶抑制剂法舒地尔对血管痉挛性心绞痛患者的冠状动脉痉挛的抑制作用”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    The possibility of pleiotropic effects of Novel Oral Anticoagulants (NOAC) on Rho-kinase-cyclophilin A System
    • 批准号:
      25670379
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2013
    • 负责人:
      SHIMOKAWA Hiroaki
    • 依托单位:
    The role of SmgGDS in the pleiotropic effects by statins
    • 批准号:
      23659071
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      SHIMOKAWA Hiroaki
    • 依托单位:
    Molecular mechanisms for NOSs-mediated responses in microvessels
    • 批准号:
      22390154
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2010
    • 负责人:
      SHIMOKAWA Hiroaki
    • 依托单位:
    Experimental and Clinical Studies on the Significance of Endothelium-Derived Hyperpolarizing Factor (EDHF)
    国内基金
    海外基金
    激活NF-κB/Rho-kinase 和TGF-β/Smads信号传导通路在术后腹膜粘连形成中的研究
    • 批准号:
      81570473
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2015
    • 负责人:
      侯连兵
    • 依托单位:
    阿魏酸通过RhoA/Rho-kinase信号通道降低肝硬化门脉压力的分子机制
    • 批准号:
      81070342
    • 项目类别:
      面上项目
    • 资助金额:
      32.0万元
    • 批准年份:
      2010
    • 负责人:
      周琦
    • 依托单位: